These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2873471)

  • 21. The current status of PET scanning with respect to schizophrenia.
    Sedvall G
    Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic receptor sites in human brain: positron emission tomography.
    Baron JC; Comar D; Zarifian E; Agid Y; Crouzel C; Loo H; Deniker P; Kellershohn C
    Neurology; 1985 Jan; 35(1):16-24. PubMed ID: 3871249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands.
    Farde L; Hall H
    Arzneimittelforschung; 1992 Feb; 42(2A):260-4. PubMed ID: 1316756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron emission tomography of brain dopamine D-1 receptors with 11C-SCH 23390 in Parkinson's disease.
    Rinne JO; Laihinen A; Någren K; Bergman J; Haaparanta M; Solin O; Ruotsalainen U; Rinne UK
    Acta Radiol Suppl; 1991; 376():152. PubMed ID: 1666760
    [No Abstract]   [Full Text] [Related]  

  • 25. Dopamine receptor asymmetry in schizophrenia.
    Reynolds GP; Czudek C; Bzowej N; Seeman P
    Lancet; 1987 Apr; 1(8539):979. PubMed ID: 2882367
    [No Abstract]   [Full Text] [Related]  

  • 26. Utilization of radioligands in schizophrenia research.
    Sedvall G; Farde L; Hall H; Halldin C; Karlsson P; Nordström AL; Nyberg S; Pauli S
    Clin Neurosci; 1995; 3(2):112-21. PubMed ID: 7583617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of the time-course of dopamine D2 receptor occupancy in living human brain from plasma pharmacokinetics of antipsychotics.
    Takano A; Suhara T; Ikoma Y; Yasuno F; Maeda J; Ichimiya T; Sudo Y; Inoue M; Okubo Y
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):19-26. PubMed ID: 14764214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Buchsbaum MS
    Neuropsychopharmacology; 1992 Aug; 7(1):67-8; discussion 73-5. PubMed ID: 1355970
    [No Abstract]   [Full Text] [Related]  

  • 29. Imaging dopamine transmission in schizophrenia. A review and meta-analysis.
    Laruelle M
    Q J Nucl Med; 1998 Sep; 42(3):211-21. PubMed ID: 9796369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine D4 receptors elevated in schizophrenia.
    Seeman P; Guan HC; Van Tol HH
    Nature; 1993 Sep; 365(6445):441-5. PubMed ID: 8413587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine receptors in post-mortem schizophrenic brains.
    Reynolds GP
    Lancet; 1981 Jun; 1(8232):1261. PubMed ID: 6112585
    [No Abstract]   [Full Text] [Related]  

  • 32. Brain dopamine receptor densities in schizophrenics.
    Iversen LL; Mackay AV
    Lancet; 1981 Jul; 2(8238):149. PubMed ID: 6113506
    [No Abstract]   [Full Text] [Related]  

  • 33. Schizophrenia: a scientific delusion with long-lasting computer virus-like action on human thought?
    Elomaa E
    Med Hypotheses; 1995 Feb; 44(2):110. PubMed ID: 7596302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical brain anatomy in schizophrenia.
    Sedvall G; Farde L
    Lancet; 1995 Sep; 346(8977):743-9. PubMed ID: 7658878
    [No Abstract]   [Full Text] [Related]  

  • 35. In vivo measurement of dopamine receptors in pituitary adenomas using positron emission tomography.
    Muhr C; Bergström M; Lundberg PO; Bergström K; Långström B
    Acta Radiol Suppl; 1986; 369():406-8. PubMed ID: 2980511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic and benzodiazepine receptors studied in vivo by PET.
    Hantraye P; Mazière B; Mazière M; Fukuda H; Naquet R
    J Physiol (Paris); 1986; 81(4):278-82. PubMed ID: 3033225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
    Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
    Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G; Landvogt C; Vernaleken I; Buchholz HG; Ondracek J; Siessmeier T; Härtter S; Schreckenberger M; Stoeter P; Hiemke C; Rösch F; Wong DF; Bartenstein P
    Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dopamine receptors].
    Terai M; Usuda S; Maeno H
    Tanpakushitsu Kakusan Koso; 1984 Nov; 29(12 Suppl):1328-37. PubMed ID: 6241319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.